JEFFREY ROTH: Open Payments
NPI 1992424923 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 11 payments from 8 companies in 2025. Trend: 2023 $256 · 2024 $84 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| UCB, Inc. | 1 | $37 |
| Dexcom, Inc. | 1 | $33 |
| Eisai Inc. | 1 | $25 |
| ARGENX US, INC. | 1 | $19 |
| Lundbeck LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: KESIMPTA, QULIPTA, Rystiggo, Dexcom G6 Transmitter, Leqembi, UBRELVY, VYVGART HYTRULO, VYEPTI.
Industry payments across AZ — which companies pay providers there.
